Reagent and method for TBG assay

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 12, 23230B, 232306, G01N 3300, A61K 3900

Patent

active

040326268

ABSTRACT:
The concentration of thyroxine binding globulin (TBG) in a fluid sample can be determined via radioassay technique with an immunochemical composite comprising anti-TBG antibodies immobilized on a water-insoluble carrier. The composite is incubated with the sample in a quantity sufficient to assure complexation of substantially all TBG in the sample to the antibodies of the composite. The quantity of TBG complexed is determined with radiolabeled thyroxine (T.sub.4) which complexes with at least a portion of the complexed TBG. By separating the labeled composite from the remaining labeled T.sub.4, and counting the bound (or unbound) T.sub.4, the concentration of TBG can be determined from a standard curve.

REFERENCES:
patent: 3933997 (1976-01-01), Hersh et al.
patent: 3960492 (1976-06-01), DiGiulio
patent: 3975511 (1976-08-01), Vann et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Reagent and method for TBG assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reagent and method for TBG assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagent and method for TBG assay will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1521814

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.